NCT07277413 2026-01-20A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsIDEAYA BiosciencesPhase 1 Recruiting260 enrolled
NCT04272034 2025-10-16Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated105 enrolled
NCT05107674 2025-09-09A Study of NX-1607 in Adults With Advanced MalignanciesNurix Therapeutics, Inc.Phase 1 Recruiting345 enrolled
NCT03126110 2025-08-14Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 Combined With Immune Therapies in Advanced or Metastatic MalignanciesIncyte CorporationPhase 1/2 Completed145 enrolled 47 charts
NCT05714553 2025-07-18NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursNuCana plcPhase 1/2 Terminated19 enrolled
NCT04242199 2025-07-14Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Completed182 enrolled